122 related articles for article (PubMed ID: 37031549)
1. Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran.
Amiri Z; Azmin M; Amiri S; Akbarisari A; Sahraian MA; Farzadfar F; Soleymani F
Mult Scler Relat Disord; 2023 Jun; 74():104693. PubMed ID: 37031549
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.
Molina MJ; Mayor AM; Franco AE; Morell CA; López MA; Vilá LM
J Clin Rheumatol; 2007 Aug; 13(4):202-4. PubMed ID: 17762454
[TBL] [Abstract][Full Text] [Related]
3. Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
Marrie RA; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Wolfson C; Patten SB; Svenson LW; Tremlett H; Fisk J; Blanchard JF;
Mult Scler; 2012 Sep; 18(9):1310-9. PubMed ID: 22328682
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.
Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
Neurology; 2024 Mar; 102(5):e209135. PubMed ID: 38350062
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland.
Kapica-Topczewska K; Tarasiuk J; Chorąży M; Czarnowska A; Brola W; Szczepański M; Kochanowicz J; Kułakowska A
Mult Scler Relat Disord; 2020 Jun; 41():102051. PubMed ID: 32197130
[TBL] [Abstract][Full Text] [Related]
6. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study.
Lin HC; Chien CW; Hu CC; Ho JD
Ophthalmology; 2010 Nov; 117(11):2088-95. PubMed ID: 20570357
[TBL] [Abstract][Full Text] [Related]
7. Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data.
Ogino M; Shiozawa A; Ota H; Okamoto S; Hiroi S; Kawachi I
Neurodegener Dis Manag; 2018 Apr; 8(2):97-103. PubMed ID: 29694267
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.
Maric GD; Pekmezovic TD; Mesaros ST; Tamas OS; Ivanovic JB; Martinovic VN; Andabaka MM; Jovanovic AL; Veselinovic ND; Kisic-Tepavcevic DB; Drulovic JS
Neurol Sci; 2021 May; 42(5):1887-1893. PubMed ID: 32964347
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.
Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
Reumatismo; 2017 Aug; 69(2):47-58. PubMed ID: 28776358
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy).
Bezzini D; Gualdani E; Razzanelli M; Battaglia MA; Cortese R; Francesconi P; Ulivelli M
Neurol Sci; 2022 Nov; 43(11):6407-6414. PubMed ID: 35978257
[TBL] [Abstract][Full Text] [Related]
12. Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada.
Marshall DA; Liu X; Barnabe C; Yee K; Faris PD; Barber C; Mosher D; Noseworthy T; Werle J; Lix L
BMJ Open; 2019 Nov; 9(11):e033334. PubMed ID: 31753902
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.
Rotstein D; Maxwell C; Tu K; Gatley J; Pequeno P; Kopp A; Marrie RA
Mult Scler; 2021 Oct; 27(12):1902-1913. PubMed ID: 34328821
[TBL] [Abstract][Full Text] [Related]
15. Estimating the burden of disease. Comparing administrative data and self-reports.
Robinson JR; Young TK; Roos LL; Gelskey DE
Med Care; 1997 Sep; 35(9):932-47. PubMed ID: 9298082
[TBL] [Abstract][Full Text] [Related]
16. Editor's Choice - Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data.
Kreutzburg T; Peters F; Rieß HC; Hischke S; Marschall U; Kriston L; L'Hoest H; Sedrakyan A; Debus ES; Behrendt CA
Eur J Vasc Endovasc Surg; 2020 Jan; 59(1):59-66. PubMed ID: 31744786
[TBL] [Abstract][Full Text] [Related]
17. Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Marrie RA; Fisk JD; Yu BN; Leung S; Elliott L; Caetano P; Warren S; Evans C; Wolfson C; Svenson LW; Tremlett H; Blanchard JF; Patten SB;
BMC Neurol; 2013 Feb; 13():16. PubMed ID: 23388102
[TBL] [Abstract][Full Text] [Related]
18. Real-world burden of comorbidities in US patients with psoriasis.
Shah K; Mellars L; Changolkar A; Feldman SR
J Am Acad Dermatol; 2017 Aug; 77(2):287-292.e4. PubMed ID: 28623046
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
Iljicsov A; Milanovich D; Ajtay A; Oberfrank F; Bálint M; Dobi B; Bereczki D; Simó M
PLoS One; 2020; 15(7):e0236432. PubMed ID: 32716953
[TBL] [Abstract][Full Text] [Related]
20. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
